» Articles » PMID: 35671359

Transseptal Puncture for Left Atrial Ablation: Risk Factors for Cardiac Tamponade and a Proposed Causative Classification System

Abstract

Aims: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the associations of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our center from 2016 to 2020.

Methods And Results: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinized to adjudicate TSP culpability. Adjusted multivariate analysis examined predictors of TRCT. A total of 3239 consecutive TSPs were performed; cardiac tamponade occurred in 51 patients (incidence: 1.6%) and was adjudicated as TSP-related in 35 (incidence: 1.1%; 68.6% of all tamponades). Patients of above-median age [odds ratio (OR): 2.4 (1.19-4.2), p = .006] and those undergoing re-do procedures [OR: 1.95 (1.29-3.43, p = .042] were at higher risk of TRCT. Of the operator-dependent variables, choice of transseptal needle (Endrys vs. Brockenbrough, p > .1) or puncture sheath (Swartz vs. Mullins vs. Agilis vs. Vizigo vs. Cryosheath, all p > .1) did not predict TRCT. Adjusting for operator, equipment and demographics, failure to cross the septum first pass increased TRCT risk [OR: 4.42 (2.45-8.2), p = .001], whilst top quartile operator experience [OR: 0.4 (0.17-0.85), p = .002], transoesophageal echocardiogram [TOE prevalence: 26%, OR: 0.51 (0.11-0.94), p = .023], and use of the SafeSept transseptal guidewire [OR: 0.22 (0.08-0.62), p = .001] reduced TRCT risk. An increase in transseptal guidewire use over time (2016: 15.6%, 2020: 60.2%) correlated with an annual reduction in TRCT (R  = 0.72, p < .001) and was associated with a relative risk reduction of 70%.

Conclusions: During left atrial ablation, the risk of TRCT was reduced by operator experience, TOE-guidance, and use of a transseptal guidewire, and was increased by patient age, re-do procedures, and failure to cross the septum first pass.

Citing Articles

The US4ABL Strategy: A Systematic Ultrasound-Guided Approach for Left Atrial and Ventricular Ablation Procedures.

Bejinariu A, Augustin N, Spieker M, Auf der Heiden C, Angendohr S, Hockmann M J Clin Med. 2025; 14(1.

PMID: 39797186 PMC: 11722390. DOI: 10.3390/jcm14010103.


2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J J Arrhythm. 2024; 40(6):1217-1354.

PMID: 39669937 PMC: 11632303. DOI: 10.1002/joa3.13082.


Needle-free atrial transseptal access: A safe and reproducible alternative for left atrial catheterization.

Pacheco-Bouthillier A, Miguel-Gonzalez J, Gonzalez-Martinez A, Everding-Rodriguez A, Gomez-Delgadillo S, Chavez-Torres A Heart Rhythm O2. 2024; 5(11):788-795.

PMID: 39651438 PMC: 11624409. DOI: 10.1016/j.hroo.2024.09.005.


Decoding the evidence: A synopsis of indications and evidence for catheter ablation in atrial fibrillation (Review).

Obeidat O, Ismail M, Abughazaleh S, Al-Ani H, Tarawneh M, Alhuneafat L Med Int (Lond). 2024; 5(1):1.

PMID: 39563946 PMC: 11571048. DOI: 10.3892/mi.2024.200.


Impact of overweight and obesity on radiation dose and outcome in patients undergoing pulmonary vein isolation by cryoballoon and pulsed field ablation.

Jungen C, Rattka M, Bohnen J, Mavrakis E, Vlachopoulou D, Dorna S Int J Cardiol Heart Vasc. 2024; 55:101516.

PMID: 39403597 PMC: 11471536. DOI: 10.1016/j.ijcha.2024.101516.


References
1.
Imnadze G, Ajaj T, Bante H, Sohns C, Sommer P . Transseptal puncture without fluoroscopy using a radiofrequency needle: A case series. Cardiol J. 2020; 28(5):655-662. PMC: 8428929. DOI: 10.5603/CJ.a2020.0008. View

2.
Friedman D, Pokorney S, Ghanem A, Marcello S, Kalsekar I, Yadalam S . Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation. JACC Clin Electrophysiol. 2020; 6(6):636-645. DOI: 10.1016/j.jacep.2020.01.011. View

3.
Marcus G, Ren X, Tseng Z, Badhwar N, Lee B, Lee R . Repeat transseptal catheterization after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2006; 18(1):55-9. DOI: 10.1111/j.1540-8167.2006.00657.x. View

4.
Yanagisawa S, Inden Y, Ohguchi S, Nagao T, Fujii A, Tomomatsu T . Periprocedural Management of Cardiac Tamponade During Catheter Ablation for AF Under Uninterrupted DOAC and Warfarin. JACC Clin Electrophysiol. 2020; 6(7):786-795. DOI: 10.1016/j.jacep.2020.02.005. View

5.
Bollmann A, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Sause A . Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER). Europace. 2018; 20(12):1944-1951. DOI: 10.1093/europace/euy131. View